TFEB and metabolic dysfunction-associated steatotic liver disease: Recently, a study has revealed that the inhibition of TFEB and impairment of autophagy in the liver of patients with NAFLD led to the continuous accumulation of lipids in the liver (Qian et al., 2021), ultimately resulting in the development of end-stage liver disease (Zhang et al., 2018).